Tag: CSE: SILO

June 17, 2021

Silo Wellness and Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Announces Psychedelics Genetic Test Kit Partnership

Silo Wellness Inc. (“Silo Wellness” or “the Company”) (CSE: SILO) (FRA: 3K70) (OTC: SILFF) and Entheon Biomedical Corp. (CSE: ENBI)...
April 15, 2021

Silo Wellness Announces Intellectual Property Licensing Agreement of Psilocybin Nasal Spray in Colombia and Brasil

Silo Wellness Inc. has signed a binding Letter of Intent for a multi-year patent licensing agreement with Jungle Med Inc....